Exec Chat: Boston Scientific’s Angelo De Rosa Forsees Digital Transformation In The COVID-19 Era
Executive Summary
Angelo De Rosa, VP of Boston Scientific's cardiac rhythm management business in Europe, the Middle East and Africa, talked to Medtech Insight about the opportunities to accelerate digital transformation in health care during the COVID-19 crisis.
You may also be interested in...
Competent Authorities Warn EU Industry Not To Expect All MDR Implementation Tools In Time
Preparing all items needed to support the implementation of the EU’s Medical Device and IVD Regulations in time is going to be impossible. Competent authority expert Thomas W Møller explains how work on a third of implementation tasks still remains to be started.
Beyond COVID-19: Industry Insiders Offer 10 Strategies For Medtech Recovery
Medtech insiders offer 10 strategies for medtech companies to rethink their businesses right now.
Boston Scientific Sees Grim Q2 But Eyes Growth By Q4 Fueled By Product Launches
The big news at Boston Scientific's first-quarter earnings call was how badly the pandemic had impacted the second quarter so far, with sales down almost $500m in April. But the company said it already saw signs that procedure volumes were beginning to bounce back.